Detalhe da pesquisa
1.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34984808
2.
Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.
Diabetes Care
; 46(8): 1524-1530, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37343574
3.
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
Diabetes Care
; 46(5): 1046-1051, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36897834